These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26491951)

  • 1. Long-term assessment of effectiveness and quality of life of OnabotulinumtoxinA injections in provoked vestibulodynia.
    Pelletier F; Girardin M; Humbert P; Puyraveau M; Aubin F; Parratte B
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):106-11. PubMed ID: 26491951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study.
    Petersen CD; Giraldi A; Lundvall L; Kristensen E
    J Sex Med; 2009 Sep; 6(9):2523-37. PubMed ID: 19619148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials.
    Everaert K; Gruenenfelder J; Schulte-Baukloh H; Egerdie RB; Khalaf K; Joshi M; Ni Q; Sussman D
    Int J Urol; 2015 Dec; 22(12):1131-7. PubMed ID: 26391359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.
    Guerzoni S; Pellesi L; Baraldi C; Pini LA
    J Headache Pain; 2015; 17():48. PubMed ID: 27146068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis.
    Diomande I; Gabriel N; Kashiwagi M; Ghisu GP; Welter J; Fink D; Fehr MK; Betschart C
    Arch Gynecol Obstet; 2019 Apr; 299(4):993-1000. PubMed ID: 30707361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia.
    Pelletier F; Parratte B; Penz S; Moreno JP; Aubin F; Humbert P
    Br J Dermatol; 2011 Mar; 164(3):617-22. PubMed ID: 21275944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum Toxin A for Provoked Vestibulodynia: 12 Months' Follow-up of a Randomized Controlled Trial.
    Haraldson P; Mühlrad H; Heddini U; Nilsson K; Bohm-Starke N
    J Sex Med; 2022 Nov; 19(11):1670-1679. PubMed ID: 36307361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
    Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Toxin A as a Treatment for Provoked Vestibulodynia: A Randomized Controlled Trial.
    Haraldson P; Mühlrad H; Heddini U; Nilsson K; Bohm-Starke N
    Obstet Gynecol; 2020 Sep; 136(3):524-532. PubMed ID: 32769643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia.
    Spoelstra SK; Dijkstra JR; van Driel MF; Weijmar Schultz WC
    J Sex Med; 2011 Feb; 8(2):489-96. PubMed ID: 20646179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study.
    Villa-Muñoz P; Albaladejo-Belmonte M; Nohales-Alfonso FJ; Alberola-Rubio J; Garcia-Casado J
    Toxins (Basel); 2023 Jul; 15(8):. PubMed ID: 37624233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.
    Jog M; Wein T; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
    Can J Neurol Sci; 2016 Sep; 43(5):687-96. PubMed ID: 27430524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results.
    Giannantoni A; Proietti S; Giusti G; Gubbiotti M; Millefiorini E; Costantini E; Berardelli A; Conte A
    World J Urol; 2015 Dec; 33(12):2095-101. PubMed ID: 25966660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of transcranial direct-current stimulation (tDCS) in women with provoked vestibulodynia: study protocol for a randomized controlled trial.
    Morin A; Léonard G; Gougeon V; Waddell G; Bureau YA; Girard I; Morin M
    Trials; 2016 May; 17(1):243. PubMed ID: 27179944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data.
    Davies B; Gaul C; Martelletti P; García-Moncó JC; Brown S
    J Headache Pain; 2017 Sep; 18(1):93. PubMed ID: 28879545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vestibulodynia: Clinical characteristics, first-line treatments, and factors associated with escalation of treatment with EMG-guided injections of botulinum toxin in a retrospective french cohort study.
    Neuville C; Parratte B; Lombion S; Aubin F; Gallais Sérézal I; Pelletier F
    Ann Dermatol Venereol; 2024 Jun; 151(2):103277. PubMed ID: 38678773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Cognitive-Behavioral Therapy and Physical Therapy for Provoked Vestibulodynia: A Randomized Pilot Study.
    Goldfinger C; Pukall CF; Thibault-Gagnon S; McLean L; Chamberlain S
    J Sex Med; 2016 Jan; 13(1):88-94. PubMed ID: 26755091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.
    Kollewe K; Escher CM; Wulff DU; Fathi D; Paracka L; Mohammadi B; Karst M; Dressler D
    J Neural Transm (Vienna); 2016 May; 123(5):533-40. PubMed ID: 27032774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.